Abstract
Cystic fibrosis (CF) is a genetic disorder affecting epithelial ion transport, which among other impacts results in defective mucociliary clearance and innate defenses in the respiratory tract. Consequently, people with CF experience lifelong infections of the respiratory mucosa that are chronic and polymicrobial in nature. Young children with CF are initially colonized by opportunists like nontypeable Haemophilus influenzae (NTHi), which normally resides within the microbiome of the nasopharynx and upper airways and can also cause infections of the respiratory mucosa that include bronchitis and otitis media. NTHi is typically supplanted by other microbes as patients age; for example, people with CF are often chronically infected with mucoid strains of Pseudomonas aeruginosa , which prior work in our laboratory has shown to promote colonization and persistence by other opportunists that include Stenotrophomonas maltophilia . Our previous work has shown that polymicrobial infection impacts host colonization and persistence of incoming microbes via diverse mechanisms that include priming of host immunity that can promote microbial clearance, and cooperativity within polymicrobial biofilms, which can promote persistence. In infection studies with BALB/c Cftrtm1UNC mice, results showed, as previously observed for WT BALB/c mice, preceding infection with NTHi decreased colonization and persistence by P. aeruginosa . Likewise, polymicrobial infection of BALB/c Cftrtm1UNC and C57BL/6 Cftrtm1UncTg(FABPhCFTR)1Jaw/J mice showed correlation between S. maltophilia and P. aeruginosa , with increased bacterial colonization and lung pathology. Based on these results, we conclude that our previous observations regarding polymicrobial infections with CF opportunists in WT mice are also validated using CF mice.
Keywords: airway infection, bacteria, Cystic fibrosis, polymicrobial
Introduction
Cystic fibrosis (CF) is a genetic disorder caused by mutations affecting an epithelial ion transporter, the cystic fibrosis transmembrane conductance regulator (CFTR) [1, 2]. CFTR deficits have many pathological consequences, including impairment of mucociliary clearance and innate immune defenses in the airways. As a result, people with CF experience lifelong opportunistic infections of the airway mucosa, which are significant contributors to CF morbidity and mortality [3, 4]. The microbiome of the lungs of persons with CF are complex, dynamic and constantly changing, and undergoes predictable shifts in dominant microbial phyla that can correlate with changes in respiratory function and overall health [5–7]. Defining mechanisms that govern interbacterial cooperation and/or competition within the CF lung, and their impacts on patient health outcomes are central questions in our work on CF-related infections.
Children experience colonization of the nasopharynx and upper airways early in life with airway commensals such as nontypeable Haemophilus influenzae , Moraxella catarrhalis and Streptococcus pneumoniae ; for children with CF, the carriage of these organisms extends throughout the lung and lower airways [8, 9]. As patients age, these microbes are gradually supplanted by other bacterial species, most notably mucoid variants of Pseudomonas aeruginosa, which often correlates with declining respiratory function and worsened disease outcomes [10, 11]. Our recent work showed that in experimental mouse respiratory infections, NTHi diminishes colonization and persistence of P. aeruginosa by priming of innate host defenses [12]. Conversely, in separate studies, we also showed that P. aeruginosa can promote colonization of other bacteria, namely Stenotrophomonas maltophilia , by means of cooperative persistence within polymicrobial biofilms [13]. In this work, we extend these findings to the context of CF using CF mutant mice. Mice harbouring CFTRtmc1UNC mutations were the first CF animal models generated for research use; however, inherent intestinal obstruction notoriously led to the premature demise of these mice; in response, bitransgenic mice expressing rat fatty acid binding protein 2 and an intestinal promotor for human CFTR (FABPhCFTR) were generated, extending survival to maturity [14]. Herein, CF mutant mice with CFTRtmc1UNC mutations in two genetic backgrounds [BALB/c CFTRtmc1UNC or C57Bl/6 Cftrtm1UncTg(FABPhCFTR)1Jaw/J] were infected with various combinations of bacterial species as in the previous studies, and compared at differing time points post-infection for lung bacterial burden, immune cell influx into bronchoalveolar lavage fluid (BALF), histopathological damage and cytokine/chemokine markers of immunological response. Our findings suggest that previously established polymicrobial interactions do not differ in these CF models compared to non-CF mice, but that the background of these CF mouse models can impact immune sequelae and pathology following infection.
Methods
Bacterial strains and growth conditions
For S. maltophilia and P. aeruginosa studies, strain S. maltophilia K279a, a widely used model strain with a fully annotated genome, was provided by M. Herman (Kansas State University) [15]. Strain P. aeruginosa mPA08-31, a sputum-derived CF clinical isolate, was obtained from S. Birket (University of Alabama at Birmingham). All strains were routinely cultured on Luria–Bertani (LB) agar (Difco) or in LB broth. S. maltophilia was streaked for colony isolation before inoculation into LB broth and shaking overnight at 30 °C and 200 r.p.m. P. aeruginosa was streaked for colony isolation before inoculation into LB broth and shaking overnight at 37 °C and 200 r.p.m.
For nontypeable H. influenzae and P. aeruginosa studies, strain NTHi HI-1, a CF clinical isolate, was provided by Timothy Starner, University of Iowa Children’s Hospital. NTHi was routinely cultured on supplemented brain-heart infusion (sBHI) agar (RPI, ThermoFisher Scientific), containing 10 µg ml−1 of hemin (Sigma Aldrich, St. Louis, MO, USA) and 1 µg ml−1 of NAD (Sigma Aldrich). NTHi was cultured on supplemented BHI agar, incubated overnight at 37 °C+5 % CO2. Strain P. aeruginosa mPA 08–31 was cultured in LB broth and shaking overnight at 37 °C and 200 r.p.m.
Mouse model of infection
Cystic fibrosis mouse models, including BALB/c Cftrtm1UNC (JAX no. 002196) and C57BL/6J- Cftrtm1UncTg(FABPhCFTR)1Jaw/J (JAX no. 002364) backgrounds with CFTR null mutations, were obtained from the Cystic Fibrosis Mouse Model core at the University of Alabama at Birmingham (UAB). All mice received supplemental diet, in addition to standard chow, of DietGel dietary supplement (ClearH2O, Westbrook, ME, USA) and Pedialyte (Abbott, Chicago, IL, USA). At 6–8 weeks of age, mice were anesthetized with isoflurane and intratracheally infected via tracheal cannulation. In short, anesthetized mice were vertically suspended on an intubation board (BioLite, Braintree Scientific, Braintree, MA, USA) blunt forceps were used to position the tongue, and bacterial inoculum was administered directly into the trachea via a 21 gauge cannula attached to a syringe. Mice were allowed to hang vertically until all liquid was aspirated and were closely monitored until respiration returned to normal. Uninfected control mice were administered a volume equivalent dose of PBS vehicle (100 µl). Weight was recorded prior to infection and monitored every 24 h post-infection. Weight loss was not reported for animals that expired prematurely. All mouse infection protocols were approved by the UAB Institutional Animal Care and Use Committees.
For nontypeable H. influenzae and P. aeruginosa studies, mice were infected with ~107 c.f.u. ml−1 of NTHi followed 24 h later by ~108 c.f.u. ml−1 of P. aeruginosa , essentially as we have described previously [12]. Endpoints of respiratory infection were assessed 72 h post-dual challenge. To determine the bacterial burden of the lungs, the left lung of each mouse was harvested and homogenized with stainless steel beads in 500 µl of sterile PBS (30 Hz s−1 for 3 min). Lung homogenates were serially diluted in PBS and plated on selective media. NTHi bacteria were enumerated by plate count using sBHI agar, except for coinfected mice in which case the NTHi were enumerated on sBHI with spectinomycin (2 mg ml−1) for selection of NTHi. Animals that expired before the end of the study were shown in bacterial enumeration counts as 1×109 c.f.u./lung.
For S. maltophilia and P. aeruginosa studies, mice were infected with ~108 c.f.u. ml−1 of each species and endpoints were assessed 24 h post-infection. Lung homogenates were serially diluted in PBS and plated on selective media. Single-species infected lungs were plated on LB, while dual-species infected lungs were plates on LB agar containing gentamicin (50 µg ml−1) for quantification of S. maltophilia . Animals that expired before the end of the study were shown in bacterial enumeration counts as 1×109 c.f.u./lung.
Histological analyses
For histological analyses, the right lung of each mouse was perfused with PBS, inflated with 10% buffered formalin (ThermoFisher Scientific, Waltham, MA, USA), and stored at 4 °C until processing. Slices from each lobe of the right lung were trimmed and sent to the UAB Comparative Pathology Laboratory to be processed, paraffin embedded, sectioned onto slides and stained with hematoxylin and eosin (H and E). Semiquantitative grading of histopathological changes of all lung sections was performed by a board-certified surgical pathologist (L.N.). Severity of lung tissue injury included alveolar, peribronchial inflammation, perivascular neutrophil infiltration, pleuritis and tissue necrosis. Severity of tissue damage from all lung lobes was graded. Grade 0 showed no neutrophil infiltrate in lung tissue; grade 1 showed rare neutrophils in the alveolar, peribronchial or perivascular tissue; grade 2 showed dense neutrophil infiltrate within the alveolar spaces with no injury to alveolar tissue; grade 3 showed dense neutrophil infiltrate within the alveolar space and necrosis of involved alveolar tissue. H-score is a cumulative score, determined by the percentage of tissue area assigned each grade (0–3). Maximum grade was assigned to the most severely damaged lobe, representing the maximum infection per animal. Images of lung sections were taken on a Lionheart FX Automated Imaging microscope (BioTek, Winooski, VT, USA) using 10× objective. Scale bar represents 200 µm.
Bronchoalveolar lavage fluid
Bronchoalveolar lavage was performed by flushing lungs with 5–6 ml of PBS in 1 ml increments as previously described [12, 16]. Collected bronchoalveolar lavage fluid (BALF) was stored on ice until processing. The first 1 ml increment was centrifuged (1350 g , 5 min) to separate the supernatant from immune cells and the cell pellet was used for total and differential cell counts. The remaining 4–5 ml of collected BALF were centrifuged to remove debris (1350 g , 5 min) and supernatant was stored at −20 °C until use for cytokine analyses.
Differential cell counting and cytokine analyses
For total and differential cell counts, cell pellets from BALF were resuspended in sterile PBS and mounted on a slide by cytospin (500 r.p.m. for 5 min). Cells were stained with a Kwik-Diff differential cell stain (ThermoFisher). Three representative fields of view from each slide were counted to determine immune cell counts. Cytokine/chemokines were measured in undiluted BALF by a custom Milliplex mouse Cytokine magnetic panel (MilliporeSigma, St. Louis, MO, USA).
Statistical analyses
Graphs depict sample means±standard error of the mean (sem). Mouse numbers within each group are denoted in the figure legends. Following the Shapiro–Wilk normality test, nonparametric data sets were analysed by the Kruskal–Wallis test with the uncorrected Dunn’s test for multiple comparisons. Comparisons between CFTR mutant mice and their WT littermates were evaluated against infection status (two factors), measured by two-way ANOVA with Sidak’s multiple comparison test; P-values≤0.05 were considered statistically significant. All statistical tests were performed using GraphPad Prism 9 (San Diego, CA, USA).
Results
Preceding infection with nontypeable H. influenzae decreases colonization/persistence of P. aeruginosa in BALB/c Cftrtm1UNC mice
In previous work, we showed that preceding infection with nontypeable H. influenzae impacted subsequent infection with P. aeruginosa , resulting in decreased bacterial burden and airway tissue damage documented by histopathologic examination [12]. To study these CF pathogens in a disease-specific model, we compared infection outcomes of BALB/c Cftrtm1UNC mice to that of WT, age matched littermates. Mice were intratracheally infected with NTHi HI-1 followed 24 h later by P. aeruginosa (Fig S1A, available in the online version of this article). As expected, at 48 h post-dual infection, the bacterial burden of P. aeruginosa recovered from lung homogenate was significantly reduced in mice with prior NTHi challenge compared to mice infected with P. aeruginosa alone (***P<0.001). Interestingly, there were no statistically significant differences in bacterial counts between WT and CF mice within each group (Fig. 1a). To evaluate overall animal health, percent initial weight was calculated as a metric of weight loss over the course of infection. In both WT and CF mice from each infection group, bacterial challenge resulted in significant weight loss compared to mock-infected controls receiving vehicle (PBS), with no difference between WT and CF groups (Fig. 1b). Immune cell infiltrates in BALF were quantified by cytospin preparation and differential staining. There were no significant differences noted in total immune cell infiltrates between bacterial infection groups, and a difference in total immune cell counts between WT and CF groups only under mock-infected conditions (***P<0.001) (Fig. 1c). The percentage of PMN in BALF following P. aeruginosa single-species infection were elevated as compared to other groups, and were significantly increased compared to uninfected controls (***P<0.001). However, there was no significant difference in PMN percentage between WT and CF groups, except for between uninfected CF mice and their WT littermates (*P<0.05) (Fig. 1d). The composition of total cells made up of macrophages and lymphocytes was inversely proportional to that of PMN percentage, with P. aeruginosa infection resulting in a lesser percentage of macrophages compared to uninfected controls (****P<0.0001), and there was no difference in macrophage percentage or lymphocyte percentage between WT and CF groups, with an exception being macrophage percentage between uninfected controls (***P<0.001) (Fig. 1e-f). Additionally, animal mortality was markedly increased by P. aeruginosa single-species infection, with 11.1 % mortality in WT and 44.4 % mortality in CF mice (Table S1). Overall, these findings support prior work in which preceding infection with NTHi reduces bacterial colonization/persistence of P. aeruginosa . This is particularly notable given the significant upper airway microbiome we have observed in most CF mutant mice. In our experience the mice have chronic nasopharyngeal colonization with a range of microbial species (data not shown), which could conceivably provide innate priming in the absence of any artificial infection. Based on these results we conclude that preceding infection with NTHi invokes innate immune priming that can significantly impact subsequent infections.
Hematoxylin and eosin (H and E) stained lung sections from BALB/c Cftrtm1UNC mice were microscopically evaluated for lung tissue damage by a pathologist (L.N.). The percentage of tissue areas categorized as specific grades (0–3) were calculated as a cumulative H-score. Following NTHi and P. aeruginosa infection, each infection group resulted in significant histopathological changes noted in the mice infected with P. aeruginosa alone (****P<0.0001) (Fig. 2a). The maximum grade following infection, representing the highest grade per animal, shows similar findings, with single-species P. aeruginosa infection resulting in the most severe damage compared to uninfected controls (****P<0.0001). However, no significant difference in score was found between WT and CF animal groups (Fig. 2b). Representative images of these lung sections indicate the severity of lung tissue injury following P. aeruginosa infection showing neutrophil influx and airway remodelling (Fig. 2c). Herein, we note that prior infection with NTHi reduces airway tissue damage caused by P. aeruginosa . These findings also indicate that lung pathology of the BALB/c Cftrtm1UNC mice does not significantly differ from WT mice in regard to lung tissue damage at this timepoint.
Our previous work showed that sequential introduction of NTHi followed by P. aeruginosa resulted in significant reduction of some inflammatory markers, including MCP-1, TNF-α and anti-inflammatory marker IL-10 in dual-infected mice compared to a single-species P. aeruginosa infection. Other inflammatory makers, including IL-1α, IL-1β and IL-6, were not different between infection groups [12]. To assess this phenotype in the BALB/c Cftrtm1UNC mouse model, we measured inflammatory markers in the BALF by multiplex assay. Infection with P. aeruginosa resulted in increased IL-1α compared to uninfected controls, with dual-species infection resulting in a slight decrease in this marker compared to single-species infections (*P<0.05) (Fig. 2d). Markers IL-1β, IL-6 and TNF-α also decreased following polymicrobial infection as compared to single-species P. aeruginosa infection, which was significantly higher than uninfected controls (****P<0.0001) (Fig. 2e-g). When comparing WT mice to their CF littermates, all measurements indicate no difference between groups, with an exception being that TNF-α levels were slightly higher in WT mice compared to CF mice (*P<0.05) (Fig. 2g). Overall, NTHi and P. aeruginosa infections in BALB/c Cftrtm1UNC mice result in similar inflammatory cytokine levels to previous findings in BALB/c mice at this timepoint.
S. maltophilia and P. aeruginosa colonization and correlation in BALB/c Cftrtm1UNC mice
In our previous work, we have shown that Stenotrophomonas maltophilia and Pseudomonas aeruginosa exist within polymicrobial biofilms on the lung mucosal surface, where polymicrobial infection results in reduced bacterial clearance of one or both organisms and increased disease consequences compared to infection with either organism [13]. Following previously established methods, we evaluated this phenotype in a BALB/c Cftrtm1UNC mouse model. CFTR mutant mice and their WT littermates were intratracheally infected with S. maltophilia and P. aeruginosa alone, or in a concurrent polymicrobial infection (Fig S1B). Mice were euthanized for bacterial quantification and assessment of host response 24 h post-infection. As expected, polymicrobial infection resulted in increases in bacterial burden of S. maltophilia compared to single-species infections (**P<0.01), with no statistically significant differences observed in bacterial counts between WT and CF mice within each group (Fig. 3a). S. maltophilia and P. aeruginosa showed a linear relationship between bacterial counts for each species in the coinfected mouse groups (R2=0.9250) (Fig. 3b). In addition to counts from lung homogenate, bacterial burden in the BALF also showed increased counts from dual-infected animals compared to a single-species infection (*P<0.05). There was no difference in bacterial counts from the BALF between WT and CF mice (Fig. 3c). Percent initial weight post-infection showed that bacterial infection impacts morbidity compared to uninfected controls, with P. aeruginosa single-species infection resulting in the most significant weight loss for both WT and CF mice (**P<0.01) (Fig. 3d). S. maltophilia and P. aeruginosa infection did not result in increased mortality at 24 h post-infection (Table S2). The immune cell infiltrates counted from BALF showed that all infection groups resulted in a significant increase in total immune cells compared to uninfected controls; however, there was no difference in total immune cell counts between WT and CF mice (Fig. 3e). The composition of these total immune cells showed increased PMN following bacterial infection for all infection groups compared to uninfected controls, with polymicrobial infection contributing to significant influx (***P<0.001). Percentages of PMN were significantly higher in uninfected CF mice compared to uninfected WT littermates (***P<0.001); however, there was no difference in WT and CF mice in any other infection groups (Fig. 3f). In a proportional manner, macrophage and lymphocyte composition of total immune cells was higher for uninfected control mice compared to other infection groups. Macrophage percentage was significantly higher in WT uninfected controls compared to CF uninfected controls (****P<0.0001). For all other infection groups, there was no difference between WT and CF mice (Fig. 3g-h). These findings establish that S. maltophilia and P. aeruginosa colonization is significantly correlated in BALB/c Cftrtm1UNC mice and that consequences of dual-species infection indicate a cooperative relationship.
Previously, immunological consequences of S. maltophilia and P. aeruginosa dual-species infections result in higher levels of IL-1α, IL-1β, IL-6, MIP-2 and MCP-1 in dual-infected mice compared to a S. maltophilia single-species infection, with no difference in TNF-α between infection groups [13]. To test these immunological trends in the BALB/c Cftrtm1UNC mouse model, we measured inflammatory markers in the BALF by multiplex assay for IL-1α, IL-1β, IL-6 and TNF-α. This assay showed similar results, in which IL-1α levels were significantly increased in dual-infected mice compared to S. maltophilia only infection (**P<0.01), and IL-1β levels showed a trending increasing in dual-infected mice compared to S. maltophilia infection. There was no difference between WT and CF groups, with an exception being increased IL-1α levels in dual-infected WT mice (**P<0.01) (Fig. 4a-b). IL-6 measurements increased following dual-infection as compared to S. maltophilia single-species infection, with a significant increase following dual-infection between CF and WT groups (***P<0.001) (Fig. 4c). TNF-α levels were not different between infection groups and were not different between WT and CF mice within each infection group, with an exception being an increase in WT mice following P. aeruginosa single-species infection (*P<0.05).
S. maltophilia and P. aeruginosa lead to lung pathology in a C57BL/6J- Cftrtm1UncTg(FABPhCFTR)1Jaw/J mouse model
While a cooperative relationship between S. maltophilia and P. aeruginosa was not altered by immunological response in the BALB/c Cftrtm1UNC CF mice, we wanted to test this polymicrobial relationship, as well as evaluate metrics of infection consequences, in the C57BL/6J- Cftrtm1UncTg(FABPhCFTR)1Jaw/J mice, which are thought to display more CF-like pathology than BALB/c Cftrtm1UNC mice [14]. This experiment allows for a direct comparison of experimental infections performed in independently derived CF mutant mice with separate host lineages. Following previously established methods, we intratracheally infected C57BL/6J- Cftrtm1UncTg(FABPhCFTR)1Jaw/J mice and age matched WT littermates with S. maltophilia and P. aeruginosa alone, or in a concurrent, polymicrobial infection (Fig S1B). At 24 h post-infection, there were no significant difference in bacterial burden of S. maltophilia and P. aeruginosa in lung homogenates following single-species or dual-species infections. There was also no difference in bacterial counts between WT and CF mice within each group (Fig. 5a). Although S. maltophilia and P. aeruginosa did not appear to be synergistically increasing counts from polymicrobial infection compared to single-species infection, there was still a linear relationship between bacterial counts for each species (R2=0.9932) (Fig. 5b). In this study, bacterial infection leads to no more weight loss than uninfected controls for WT mice; however, CF mice lost more weight following both S. maltophilia (**P<0.01) and P. aeruginosa (*P<0.05) infection compared to uninfected controls (Fig. 5c). Both polymicrobial infection and P. aeruginosa single-species infection caused significant mortality in CF mice (11.1 % for each group) (Table S3). In BALF, all infection groups resulted in a significant increase in total immune cell infiltration compared to uninfected controls and there were similar trends in total immune cell counts between WT and CF mice, with an exception being an increased influx in CF mice following polymicrobial infection (**P<0.01) (Fig. 5d). The percentage of PMN were increased following bacterial infection for all groups compared to uninfected controls, with polymicrobial infection contributing to significant influx (****P<0.0001). Percentages of PMN were significantly higher in uninfected CF mice compared to uninfected WT littermates (****P<0.0001), however, there was no difference in WT and CF mice from any other infection groups (Fig. 5e). Proportionally, macrophage and lymphocyte composition of total immune cells were higher for uninfected control mice compared to other infection groups. Macrophage percentage was significantly higher in WT uninfected controls compared to CF controls (****P<0.0001) and lymphocyte percentage was significantly higher in CF controls compared to WT controls (***P<0.001). For all other infection groups, there was no difference in macrophage or lymphocyte percentages in BALF between WT and CF mice (Fig. 5f-g). Overall, these findings suggests that S. maltophilia and P. aeruginosa correlate in a C57BL/6J- Cftrtm1UncTg(FABPhCFTR)1Jaw/J mice, but that bacterial counts and weight loss were not significantly different between infection groups.
In previous studies, S. maltophilia and P. aeruginosa polymicrobial infection resulted in more damage to the lungs than S. maltophilia single-species infection [4]. Lung pathology of the C57BL/6J- Cftrtm1UncTg(FABPhCFTR)1Jaw/J CF mice is thought to be more inflamed and, therefore, more representative of CF disease [5, 6]. To test how dual-infection may influence lung pathology, we assessed the lungs of S. maltophilia and P. aeruginosa infected C57BL/6J- Cftrtm1UncTg(FABPhCFTR)1Jaw/J mice and their non-CF littermates. H and E-stained lung sections were evaluated and graded by a pathologist for lung damage based on alveolar, perivascular and peribronchial inflammation, pleuritis, and tissue necrosis on a scale of 0–3. Following S. maltophilia and P. aeruginosa infection, each infection group resulted in significant airway tissue damage from bacterial infection compared to uninfected control, with both dual-infection and P. aeruginosa only infection leading to severe lung tissue damage (****P<0.0001) (Fig. 6a). The maximum grade following infection shows similar findings, with polymicrobial infection and single-species P. aeruginosa infection resulting in the most severe damage compared to uninfected controls (****P<0.0001). When comparing WT and CF infection groups, CF mice had higher composite scores for tissue damage following dual-species and P. aeruginosa single-species infection (*P<0.05) (Fig. 6b). Representative images of these lung sections show the severity of tissue damage following polymicrobial and P. aeruginosa infections characterized by neutrophil influx and alveolar tissue necrosis (Fig. 6c). These findings indicate that cooperativity, or increased dual-species infection consequences, are diminished in the Cftrtm1UncTg(FABPhCFTR)1Jaw/J CF mouse model and the development of lung injury in response to infection may be more advanced.
To assess the immunological response of C57BL/6J- Cftrtm1UncTg(FABPhCFTR)1Jaw/J mice to S. maltophilia and P. aeruginosa polymicrobial infection, we measured inflammatory markers in the BALF by multiplex assay for IL-1α, IL-1β, IL-6 and TNF-α. Following bacterial challenge, IL-1α levels were significantly higher in P. aeruginosa infected mice compared to S. maltophilia single-species infection, but there was no difference between WT and CF groups (**P<0.01) (Fig. 6d). IL-1β measurements showed the most significant readings from dual-species infection compared to uninfected controls (***P<0.001). There was no difference between WT and CF groups, with an exception being WT mice showing increased IL-1β following P. aeruginosa single-species infection (**P<0.01) (Fig. 6e). IL-6 measurements showed an increase following polymicrobial infection and P. aeruginosa single-species infection compared to uninfected controls, but there was no significant difference between CF and WT groups (**P<0.01) (Fig. 6f). TNF-α levels were elevated in S. maltophilia single-species animals and P. aeruginosa single-species animals compared to uninfected controls (**P<0.001). TNF-α was also significantly higher in WT mice following P. aeruginosa single-species infection compared to CF mice (***P<0.001). There was no difference between WT and CF mice for other infection groups (Fig. 6g). Taken together, these results support the conclusion that the C57BL/6J- Cftrtm1UncTg(FABPhCFTR)1Jaw/J CF mouse model presents subtle differences in histopathological findings and inflammatory cytokine measurements between CF mice and their WT littermates. Despite these significant but subtle differences in host response, bacterial colonization during polymicrobial infections were comparable between CF and WT mice.
Discussion
For people with CF, impaired CFTR function alters the ionic environment of the airways, a process that is thought to change the compartmental pH, reducing antimicrobial defenses, and promoting hyperinflammation [17–19]. It is well established that mucus in the CF airways, along with impaired function of host defensins and other antimicrobial factors normally found in airway surface liquid (ASL), leave patients susceptible to respiratory infection with pathogenic bacteria [17, 20]. Early-stage, acute infections require aggressive treatment, which influences the ecological shift in microbial community members over time towards those that recalcitrant to treatment [5]. As patients become persistently colonized, they experience chronic inflammation, which causes host tissue damage, stimulates mucus hypersecretion and impairs mucociliary escalator function, which in turn promotes further microbial persistence [21–23].
CF-associated infections have been extensively studied for many years, but one limiting factor has been the development and widespread availability of animal models that faithfully replicate the pathophysiology and susceptibility of patients with CF [24–27]. While it is now clear that CF mutant mice do not reliably develop spontaneous lung pathology typically observed in humans with CF disease, in some situations increased chronic inflammation and phagocytic influx into the airway in CF mice provide a model that is more susceptible to bacterial pathogens [28–33]. There remains much to be learnt about the strengths and limitations of these mice for pathogenesis studies, particularly with regard to the polymicrobial infections that are typical in the clinical course of CF disease.
The first CF mouse models of disease were generated soon after discovery of CFTR function. Of these original models, Cftrtm1UNC was one of the first described, created by a traditional route of replacement of CFTR gene, which results in complete knockout with no normal CFTR function [32, 34]. Cftrtm1UNC mice have been utilized for colonization and pathogenesis studies; however much remains to be learnt regarding polymicrobial CF infections in these mice [30, 33, 35].
Genetic background differences in BALB/c and C57BL/6 mice are known to lead to divergent immunological responses; BALB/c mice predominantly exhibit Th2 centred cellular immune responses whereas C57BL/6 mice have more Th1 dominant responses [7, 8]. Our initial infection studies focused on BALB/c Cftrtm1UN mice. As previously reported for infection studies with BALB/c mice, bacterial challenge with nontypeable H. influenzae (NTHi) and P. aeruginosa resulted in reduction of P. aeruginosa bacterial burden, with reduced inflammatory response and airway tissue damage (Fig. 1 and Fig. 2). Bacterial challenge with S. maltophilia and P. aeruginosa resulted in cooperative infection with more significant inflammatory consequences following dual infection (Figs 3–5). These experiments are consistent with our published work seen in non-CF BALB/c mice [12, 13].
C57BL/6J Cftrm1UNC/Cftrm1UNC mice were shown to have reduced mucociliary transport and evidence of fibrosis typical of that observed in patients with CF [30, 36]. One complicating issue was the development of gastrointestinal disease symptoms in these mice, which greatly impacted their survival [36]; this was later addressed by development of bitransgenic mice, expressing rat fatty acid binding protein 2 and an intestinal promoter for expression of human CFTR, creating a gut corrected model with increased survival while maintaining lung disease [14]. We used Cftrtm1Unc-Tg(FABPCFTR)1Jaw/J to evaluate lung pathology in a CF mouse as a consequence of acute bacterial infection.
Previous infection studies in Cftrtm1Unc-Tg(FABPCFTR)1Jaw/J and their non-CF littermates showed few differences in severity of lung disease following P. aeruginosa infection, but highlighted the lung functional decline associated with ageing [37]. We assessed the initial immune response aimed at bacterial clearance before lung function is thought to be impaired. Our work shows that S. maltophilia colonizes the lungs of Cftrtm1Unc-Tg(FABPCFTR)1Jaw/J at 24 h post-infection (Fig. 5A). We found that although polymicrobial infection with S. maltophilia and P. aeruginosa showed correlation in the lungs, bacterial burden and immune cell influx from polymicrobial infection did not differ significantly from that of single-species infection, indicating reduced cooperativity in this model (Fig. 5). As lung pathology representing CF disease in mouse models is uncertain, we tested the histopathological implications of S. maltophilia and P. aeruginosa infection in Cftrtm1Unc-Tg(FABPCFTR)1Jaw/J. Here, we note that Cftrtm1Unc-Tg(FABPCFTR)1Jaw/J mice showed slightly more severe pathological scores than their WT littermates, a finding represented by noticeable inflammation in lung tissue (Fig. S6). S. maltophilia and P. aeruginosa infection in Cftrtm1Unc-Tg(FABPCFTR)1Jaw/J resulted in increased influx of inflammatory cytokines, with notable increases in IL-1β and TNF-α in Cftrtm1Unc-Tg(FABPCFTR)1Jaw/J knockout mice following P. aeruginosa infection (Fig. 6). Significant influxes of these markers may indicate the magnitude of acute infection response that diverges amongst murine backgrounds.
This work is unique in evaluating the utility of several CF mouse models for study of polymicrobial respiratory infections, however, there are several limitations to consider while interpreting these results. Herein, all infections were introduced to CF mice with Cftrtm1UNC mutations, only testing the interplay of one genetic mutation background in bacterial inter-species interactions out of the many CF mouse models. Infection studies assessing NTHi/Pa dual-species infection were only performed in the BALB/c background, a factor that should be evaluated in future work assessing the role of T-cell composition on the innate immune priming response. Additionally, other animal models of CF disease may replicate more CF-like respiratory anomalies, including the CF rats, ferrets and pigs, all of which harbour submucosal glands that CF mice do not [24]. As lung microbial communities are rich in inter-species relationships, moving forward these polymicrobial infection studies will incorporate other examples of microbial interactions, such as inter-species or inter-kingdom competition, or complex infections with more than two pathogens.
In summary, this work explores the applications of CF mice to polymicrobial interactions among relevant CF pathogens. We carried out polymicrobial bacterial infections in BALB/c Cftrtm1UNC and Cftrtm1UncTg(FABPhCFTR)1Jaw/J mice, evaluating early infection response and bacterial clearance. As we have observed previously, NTHi infection caused innate immune priming that can reduce both colonization and pathology associated with subsequent P. aeruginosa infection, including bacterial burden, tissue damage and inflammatory response to P. aeruginosa [12]. Polymicrobial infections in the BALB/c Cftrtm1UNC also showed increased bacterial load and increased infectious consequences, indicating significant cooperativity between S. maltophilia and P. aeruginosa populations in vivo. With these two examples of polymicrobial infections in BALB/c Cftrtm1UNC, this model exhibits very few differences in infectious response between CF mice and their WT littermates, highlighting the limitations of its application to infection studies. S. maltophilia and P. aeruginosa dual-infections in a Cftrtm1UncTg(FABPhCFTR)1Jaw/J show significant correlation, but not promotion between these two organisms. However, both lung pathology and inflammatory response to P. aeruginosa infection of Cftrtm1UncTg(FABPhCFTR)1Jaw/J were increased compared to their non-CF littermates. Overall, our findings suggest that these CF models are equally reliable for the study of polymicrobial infections compared to non-CF mice, but that the Cftrtm1UncTg(FABPhCFTR)1Jaw/J mouse model may provide a more severe pathological response to acute respiratory infection.
Supplementary Data
Funding information
This work was supported by grants from the Cystic Fibrosis Foundation (CFFSWORDS1810, CFFSWORDS20G0) awarded to W.E.S. as well as the CF Research and Translation Core Center grant (P30DK072482) and the UAB Research and Development Program (ROWE19RO). N.R.L. was supported by a predoctoral fellowship from the Cystic Fibrosis Foundation (RDP Rowe19RO).
Acknowledgement
We thank our colleagues in the UAB Center for Cystic Fibrosis Research for their input in this work. We thank Dr Kayla Goliwas for her assistance with Bio-Plex software analyses. We thank Dr Ming Du and the UAB Cystic Fibrosis Mouse Models core for maintaining and providing CF mice. The authors would also like to thank Dr Timothy Starner (University of Iowa), Dr Susan Birket (University of Alabama at Birmingham) and Dr Michael Herman (Kansas State University) for bacterial strains used in this work, and our colleagues Susan Birket and Megan Kiedrowski for providing reviews of initial manuscript drafts.
Conflicts of interest
The authors declare that there are no conflicts of interest involved in the performance, interpretation or reporting of this work.
Ethical statement
Animal experimentation was performed in compliance with institutional and federal guidelines. In all circumstances, efforts were made to limit use of animals to the minimal numbers of mice needed for statistically valid results and to minimize pain and suffering via appropriate use of anaesthesia or analgesia. All mouse infection protocols were fully reviewed and approved by the UAB Institutional Animal Care and Use Committee and animal experimentation was carried out under the supervision of the UAB Animal Resources Program.
Footnotes
Abbreviations: ANOVA, analysis of variance; c.f.u., colony forming units.
One supplementary figure and three supplementary tables are available with the online version of this article.
References
- 1.Bobadilla JL, Macek M, Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening. Hum Mutat. 2002;19:575–606. doi: 10.1002/humu.10041. [DOI] [PubMed] [Google Scholar]
- 2.Liou TG. The clinical biology of Cystic fibrosis transmembrane regulator protein: its role and function in extrapulmonary disease. Chest. 2019;155:605–616. doi: 10.1016/j.chest.2018.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Bozzella MJ, Chaney H, Sami I, Koumbourlis A, Bost JE, et al. Impact of anaerobic antibacterial spectrum on cystic fibrosis airway microbiome diversity and pulmonary function. Pediatr Infect Dis J. 2021;40:962–968. doi: 10.1097/INF.0000000000003211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Caverly LJ, Zhao J, LiPuma JJ. Cystic fibrosis lung microbiome: opportunities to reconsider management of airway infection. Pediatr Pulmonol. 2015;50 Suppl 40:S31–8. doi: 10.1002/ppul.23243. [DOI] [PubMed] [Google Scholar]
- 5.Quinn RA, Whiteson K, Lim YW, Zhao J, Conrad D, et al. Ecological networking of cystic fibrosis lung infections. NPJ Biofilms Microbiomes. 2016;2:4. doi: 10.1038/s41522-016-0002-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev. 2002;15:194–222. doi: 10.1128/CMR.15.2.194-222.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Filkins LM, O’Toole GA. Cystic fibrosis lung infections: polymicrobial, complex, and hard to treat. PLoS Pathog. 2015;11:e1005258. doi: 10.1371/journal.ppat.1005258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Laufer AS, Metlay JP, Gent JF, Fennie KP, Kong Y, et al. Microbial communities of the upper respiratory tract and otitis media in children. mBio. 2011;2:e00245–10. doi: 10.1128/mBio.00245-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Pettigrew MM, Gent JF, Revai K, Patel JA, Chonmaitree T. Microbial interactions during upper respiratory tract infections. Emerg Infect Dis. 2008;14:1584–1591. doi: 10.3201/eid1410.080119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Malhotra S, Hayes D, Wozniak DJ. Cystic fibrosis and Pseudomonas aeruginosa: the host-microbe interface. Clin Microbiol Rev. 2019;32:e00138-18. doi: 10.1128/CMR.00138-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Zemanick ET, Emerson J, Thompson V, McNamara S, Morgan W, et al. Clinical outcomes after initial Pseudomonas acquisition in cystic fibrosis. Pediatr Pulmonol. 2015;50:42–48. doi: 10.1002/ppul.23036. [DOI] [PubMed] [Google Scholar]
- 12.Lindgren NR, Novak L, Hunt BC, McDaniel MS, Swords WE. Nontypeable haemophilus influenzae infection impedes Pseudomonas aeruginosa colonization and persistence in mouse respiratory tract. Infect Immun. 2022;90:e0056821. doi: 10.1128/IAI.00568-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.McDaniel MS, Schoeb T, Swords WE. Cooperativity between Stenotrophomonas maltophilia and Pseudomonas aeruginosa during polymicrobial airway infections. Infect Immun. 2020;88:e00855-19. doi: 10.1128/IAI.00855-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Zhou L, Dey CR, Wert SE, DuVall MD, Frizzell RA, et al. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. Science. 1994;266:1705–1708. doi: 10.1126/science.7527588. [DOI] [PubMed] [Google Scholar]
- 15.Crossman LC, Gould VC, Dow JM, Vernikos GS, Okazaki A, et al. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol. 2008;9:R74. doi: 10.1186/gb-2008-9-4-r74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Van Hoecke L, Job ER, Saelens X, Roose K. Bronchoalveolar lavage of murine lungs to analyze inflammatory cell infiltration. J Vis Exp. 2017::55398. doi: 10.3791/55398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Pezzulo AA, Tang XX, Hoegger MJ, Abou Alaiwa MH, Ramachandran S, et al. Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature. 2012;487:109–113. doi: 10.1038/nature11130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Brogden KA, Ackermann MR, McCray PB, Huttner KM. Differences in the concentrations of small, anionic, antimicrobial peptides in bronchoalveolar lavage fluid and in respiratory epithelia of patients with and without cystic fibrosis. Infect Immun. 1999;67:4256–4259. doi: 10.1128/IAI.67.8.4256-4259.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Shah VS, Meyerholz DK, Tang XX, Reznikov L, Abou Alaiwa M, et al. Airway acidification initiates host defense abnormalities in cystic fibrosis mice. Science. 2016;351:503–507. doi: 10.1126/science.aad5589. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Smith JJ, Travis SM, Greenberg EP, Welsh MJ. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell. 1996;85:229–236. doi: 10.1016/s0092-8674(00)81099-5. [DOI] [PubMed] [Google Scholar]
- 21.Locke LW, Myerburg MM, Weiner DJ, Markovetz MR, Parker RS, et al. Pseudomonas infection and mucociliary and absorptive clearance in the cystic fibrosis lung. Eur Respir J. 2016;47:1392–1401. doi: 10.1183/13993003.01880-2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Wine JJ. Measuring mucociliary transport and mucus properties in multiple regions of airway epithelial surfaces helps clarify cystic fibrosis defects. Am J Respir Crit Care Med. 2014;190:364–365. doi: 10.1164/rccm.201407-1247ED. [DOI] [PubMed] [Google Scholar]
- 23.Ratjen F, Waters V, Klingel M, McDonald N, Dell S, et al. Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia. Eur Respir J. 2016;47:829–836. doi: 10.1183/13993003.01390-2015. [DOI] [PubMed] [Google Scholar]
- 24.McCarron A, Parsons D, Donnelley M. Animal and cell culture models for cystic fibrosis: which model is right for your application? Am J Pathol. 2021;191:228–242. doi: 10.1016/j.ajpath.2020.10.017. [DOI] [PubMed] [Google Scholar]
- 25.McCarron A, Donnelley M, Parsons D. Airway disease phenotypes in animal models of cystic fibrosis. Respir Res. 2018;19:54. doi: 10.1186/s12931-018-0750-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Semaniakou A, Croll RP, Chappe V. Animal models in the pathophysiology of cystic fibrosis. Front Pharmacol. 2018;9:1475. doi: 10.3389/fphar.2018.01475. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Kukavica-Ibrulj I, Levesque RC. Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies. Lab Anim. 2008;42:389–412. doi: 10.1258/la.2007.06014e. [DOI] [PubMed] [Google Scholar]
- 28.O’Toole GA, Crabbé A, Kümmerli R, LiPuma JJ, Bomberger JM, et al. Model systems to study the chronic, polymicrobial infections in cystic fibrosis: current approaches and exploring future directions. mBio. 2021;12:e0176321. doi: 10.1128/mBio.01763-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Coleman FT, Mueschenborn S, Meluleni G, Ray C, Carey VJ, et al. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection. Proc Natl Acad Sci. 2003;100:1949–1954. doi: 10.1073/pnas.0437901100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Guilbault C, Saeed Z, Downey GP, Radzioch D. Cystic fibrosis mouse models. Am J Respir Cell Mol Biol. 2007;36:1–7. doi: 10.1165/rcmb.2006-0184TR. [DOI] [PubMed] [Google Scholar]
- 31.Guilbault C, Martin P, Houle D, Boghdady ML, Guiot MC, et al. Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique. Lab Anim. 2005;39:336–352. doi: 10.1258/0023677054306944. [DOI] [PubMed] [Google Scholar]
- 32.Snouwaert JN, Brigman KK, Latour AM, Iraj E, Schwab U, et al. A murine model of cystic fibrosis. Am J Respir Crit Care Med. 1995;151:S59–64. doi: 10.1164/ajrccm/151.3_Pt_2.S59. [DOI] [PubMed] [Google Scholar]
- 33.Cressman VL, Hicks EM, Funkhouser WK, Backlund DC, Koller BH. The relationship of chronic mucin secretion to airway disease in normal and CFTR-deficient mice. Am J Respir Cell Mol Biol. 1998;19:853–866. doi: 10.1165/ajrcmb.19.6.3194. [DOI] [PubMed] [Google Scholar]
- 34.Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, et al. An animal model for cystic fibrosis made by gene targeting. Science. 1992;257:1083–1088. doi: 10.1126/science.257.5073.1083. [DOI] [PubMed] [Google Scholar]
- 35.Davidson DJ, Rolfe M. Mouse models of cystic fibrosis. Trends Genet. 2001;17:S29–37. doi: 10.1016/s0168-9525(01)02452-0. [DOI] [PubMed] [Google Scholar]
- 36.Kent G, Iles R, Bear CE, Huan LJ, Griesenbach U, et al. Lung disease in mice with cystic fibrosis. J Clin Invest. 1997;100:3060–3069. doi: 10.1172/JCI119861. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Munder A, Wölbeling F, Kerber-Momot T, Wedekind D, Baumann U, et al. Acute intratracheal Pseudomonas aeruginosa infection in cystic fibrosis mice is age-independent. Respir Res. 2011;12:148. doi: 10.1186/1465-9921-12-148. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.